We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+3.62%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$631M
AUM Growth
-$128M
Cap. Flow
-$128M
Cap. Flow %
-20.23%
Top 10 Hldgs %
38.34%
Holding
283
New
100
Increased
32
Reduced
32
Closed
102

Sector Composition

Rank Sector Weight
1 Healthcare 24.53%
2 Technology 13.99%
3 Industrials 12.97%
4 Financials 8.91%
5 Consumer Discretionary 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BERY
151
DELISTED
Berry Global Group, Inc.
BERY
$312K 0.05%
10,781
-76,121
-88% -$1.91M
CSII
152
DELISTED
Cardiovascular Systems, Inc.
CSII
$301K 0.05%
+10,000
New +$286K
OPWR
153
DELISTED
OPOWER INC COM STK (DE)
OPWR
$301K 0.05%
+21,160
New +$343K
BEAT
154
DELISTED
BioTelemetry, Inc.
BEAT
$301K 0.05%
30,000
-20,000
-40% -$172K
ASYS icon
155
Amtech Systems
ASYS
$244M
$290K 0.05%
28,400
-58,200
-67% -$547K
TBT icon
156
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$292M
$278K 0.04%
6,000
-22,500
-79% -$1.15M
IL
157
DELISTED
IntraLinks Holdings Inc.
IL
$238K 0.04%
+20,000
New +$194K
NVS icon
158
Novartis
NVS
$299B
$232K 0.04%
2,790
CGRN
159
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$225K 0.04%
1,520
-786
-34% -$136K
ENZ
160
DELISTED
Enzo Biochem, Inc.
ENZ
$222K 0.04%
50,000
+35,000
+233% +$167K
TLGT
161
DELISTED
Teligent, Inc
TLGT
$220K 0.03%
+2,500
New +$234K
MDT icon
162
Medtronic
MDT
$112B
$217K 0.03%
+3,000
New +$208K
STRM
163
DELISTED
Streamline Health Solutions
STRM
$217K 0.03%
3,333
+333
+11% +$19.7K
EUO icon
164
ProShares UltraShort Euro
EUO
$35.6M
$216K 0.03%
+10,000
New +$204K
GLDD
165
DELISTED
Great Lakes Dredge & Dock
GLDD
$209K 0.03%
+24,400
New +$177K
BSX icon
166
Boston Scientific
BSX
$68.6B
$199K 0.03%
15,000
-10,000
-40% -$128K
HZNP
167
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$193K 0.03%
+15,000
New +$188K
EOPN
168
DELISTED
E2OPEN INC COM STK (DE)
EOPN
$192K 0.03%
+20,000
New +$143K
BWEN icon
169
Broadwind
BWEN
$88.2M
$186K 0.03%
+34,500
New +$230K
CBPX
170
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$177K 0.03%
10,000
-10,000
-50% -$159K
EHIC
171
DELISTED
eHi Car Services Limited
EHIC
$163K 0.03%
+20,014
New +$209K
AMRI
172
DELISTED
Albany Molecular Research Inc
AMRI
$163K 0.03%
+10,000
New +$184K
RITM icon
173
Rithm Capital
RITM
$5.49B
$160K 0.03%
12,500
LMAT icon
174
LeMaitre Vascular
LMAT
$2.34B
$153K 0.02%
20,000
+10,000
+100% +$71.6K
ALIM
175
DELISTED
Alimera Sciences
ALIM
$111K 0.02%
+1,333
New +$108K

Similar funds

Ardsley Advisory Partners's Q4 2014 Portfolio in Review

As of Q4 2014, Ardsley Advisory Partners held 283 positions worth $631M, down 17% from $759M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Ardsley Advisory Partners withdrew a net $128M in Q4 2014, closing 102 positions and reducing 32 holdings. Its most notable exit was Civitas Resources, an estimated $18.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, Ardsley Advisory Partners opened a new position in Community Health Systems worth $17.8M.

  • Ardsley Advisory Partners's largest Q4 2014 buy was Community Health Systems: 399,300 shares worth $17.8M.
  • Ardsley Advisory Partners added most to SolarCity Corporation in Q4 2014, an estimated $13.3M increase.
  • Ardsley Advisory Partners's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $45.2M.
  • Ardsley Advisory Partners fully exited Civitas Resources in Q4 2014, selling an estimated $18.5M.
  • Ardsley Advisory Partners's ten largest holdings make up 38% of its $631M portfolio in Q4 2014.
  • Ardsley Advisory Partners opened 100 new positions and closed 102 in Q4 2014.
  • Ardsley Advisory Partners's portfolio value fell 17% quarter-over-quarter to $631M.

Based on Ardsley Advisory Partners's 13F filing for Q4 2014, filed 17 Feb 2015.